2023 Watch List

We Would Define This as Huge News.. Citius Pharma would receive 67.5 million shares in Citius Oncology at $10 per share and retain majority ownership...

BooYah, Ardelyx shoots and we score (again) last week..but wait, there's more! It trades down post-approval as short-term impatient traders expecting a multi-dollar 'pop'...

We're up 160% ($579 million) in Ardelyx since adding it to the Watch List about ten months ago in November, but we feel the...

This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential customers. Dedicated Plan...

LIVE QUOTE Adding DarioHealth to Top Stocks of 2023 Watch List. A position in Dario Health (DRIO) offers investors a brilliant back door, into the growing...

We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company with a $80...

We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond. As the chart...

Initiating Coverage on Psycheceutical BioScience (BWVI). "Imagine Applying a Psychedelic Topically, Receiving the Benefits Quicker Than Alternative Delivery Methods (Injection, Intravenously, Nasally or Orally) and...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at real fireworks in the coming year....

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....